Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010US20100144708 Heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144706 Compounds
06/10/2010US20100144705 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010US20100144704 Method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
06/10/2010US20100144703 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
06/10/2010US20100144702 Indole compound
06/10/2010US20100144701 Modulators of CB1 Receptors
06/10/2010US20100144700 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
06/10/2010US20100144699 Combination Medicaments for Treating Bacterial Infections
06/10/2010US20100144698 Substituted azetidinones
06/10/2010US20100144697 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144696 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144695 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/10/2010US20100144694 1,2-diazetidin-3-one derivatives and drugs containing same
06/10/2010US20100144693 Method of treatment of age-related macular degeneration (amd)
06/10/2010US20100144692 Ulipristal Acetate Tablets
06/10/2010US20100144691 Treatment of Female Fertility Conditions Through Modulation of the Autonomic Nervous System
06/10/2010US20100144690 Medicaments and methods for promoting wound contraction
06/10/2010US20100144689 Compounds useful for treating neurodegenerative disorders
06/10/2010US20100144688 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids
06/10/2010US20100144687 Pharmaceutical compositions containing testosterone and an aromatase inhibitor
06/10/2010US20100144686 Topically applicable anti-inflammatory o/w emulsions comprising pro-penetrating glycols
06/10/2010US20100144685 Inhibiting cyclin d polypeptides
06/10/2010US20100144684 Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
06/10/2010US20100144683 Methods for generating mammalian models of atopic diseases, and screening for their treatment
06/10/2010US20100144681 Compounds for the treatment of alzheimer's disease
06/10/2010US20100144680 Pharmaceutical compositions useful for preventing and treating oncological diseases
06/10/2010US20100144679 Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
06/10/2010US20100144678 Compositions and methods for treating bone cancer
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144676 Oleyl phosphocholine
06/10/2010US20100144675 Regulation of sGC Function by Corrin Derivatives
06/10/2010US20100144673 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
06/10/2010US20100144671 Compositions and Methods for Cancer Treatment
06/10/2010US20100144670 Particle Formation
06/10/2010US20100144669 Dissolution and processing of cellulose
06/10/2010US20100144668 Semi-fluid food product including beta glucane fibres and guar gum, and use thereof as a functional food product
06/10/2010US20100144667 Methods for fucoidan purification from sea weed extracts
06/10/2010US20100144666 Biomaterials In the Form of Fibres for Use as Medical Devices In the Treatment of Wounds, and Their Production Process
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144664 Carbocyclic compounds and methods for treating emerging disease, including influenza and venezuela equine encephalitis virus
06/10/2010US20100144663 2, 6-Dinitrogen-Containing Substituted Purine Derivatives, The Preparation And Uses Thereof
06/10/2010US20100144662 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
06/10/2010US20100144661 Sodium channel blockers
06/10/2010US20100144660 Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer thereapy
06/10/2010US20100144659 Targeting agent for cancer cell or cancer-associated fibroblast
06/10/2010US20100144658 Novel antibiotics, bispolides a1, a2, and a3 as well as bispolides b1, b2a, b2b and b3 and processes for producing said antibiotics
06/10/2010US20100144657 PHENYLPIPERIDINE MODULATORS OF mu-OPIOID RECEPTORS
06/10/2010US20100144656 Feed or pharmaceutical composition comprising apramycin or an adequate salt thereof
06/10/2010US20100144655 Organic compounds
06/10/2010US20100144654 Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane
06/10/2010US20100144653 Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereof
06/10/2010US20100144652 Composition comprising a glycolytic inhibitor and a ring system comprising a sulphamate group for the treatment of cancer
06/10/2010US20100144651 Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use
06/10/2010US20100144650 Dimeric iap inhibitors
06/10/2010US20100144647 Dual Acting Prodrugs
06/10/2010US20100144645 Compositions and methods for enhancing analgesic potency of covalently bound-compounds, attenuating its adverse side effects, and preventing their abuse
06/10/2010US20100144639 Use of inhibitors of the egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph) / prostatic hypertrophy
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144635 Methods and compositions to treat myocardial conditions
06/10/2010US20100144628 Hepatopoietin and use thereof
06/10/2010US20100144626 Treatment of Multi-Drug Resistant Bacterial Infections
06/10/2010US20100144625 Organic Compounds
06/10/2010US20100144616 Neuroprotective methods and reagents
06/10/2010US20100144614 Altering memory by affecting staufen function
06/10/2010US20100144612 Phosphorylated pyrone analogs and methods
06/10/2010US20100144611 Treatment of t-cell mediated diseases
06/10/2010US20100144610 Pharmaceutical formulations
06/10/2010US20100144605 Rescue of gonadotropin releasing hormone receptor mutants
06/10/2010US20100144597 Novel combinatorial approaches to enhancing oxygen transport to tissues
06/10/2010US20100144594 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors
06/10/2010US20100144591 Benzimidazole derivatives and methods of use thereof
06/10/2010US20100144589 Methods of predicting cancer lethality using replikin counts
06/10/2010US20100144587 Frequency modulated drug delivery (FMDD)
06/10/2010US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations
06/10/2010US20100143513 Composition Comprising Starch Or Dietary Fiber From Gramineae Plant For Prevention And Treatment Of Ischemic Diseases And Degenerative Brain Disease
06/10/2010US20100143508 Limonene and yucca medical compound for treating human diseases and conditions
06/10/2010US20100143507 Carboxylic acid inhibitors of histone deacetylase, gaba transaminase and sodium channel
06/10/2010US20100143505 Indanone inhibitors of acetylcholinesterase
06/10/2010US20100143500 Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
06/10/2010US20100143499 Dimeric iap inhibitors
06/10/2010US20100143498 Infusion solution for peripheral intravenous administration
06/10/2010US20100143493 Ophthalmic solutions
06/10/2010US20100143486 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
06/10/2010US20100143483 Pharmaceutical compositions
06/10/2010US20100143482 Method of producing microcapsules
06/10/2010US20100143479 Method of making sustained release microparticles
06/10/2010US20100143478 Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions
06/10/2010US20100143475 Transdermal therapeutic system with two-phase release profile
06/10/2010US20100143474 B-carboline for the treatment of neurodegenerative diseases
06/10/2010US20100143473 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
06/10/2010US20100143472 Osmotic form for controlled release of active principles
06/10/2010US20100143471 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
06/10/2010US20100143470 Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
06/10/2010US20100143469 Pharmaceutical compositions
06/10/2010US20100143468 Tranexamic Acid Formulations
06/10/2010US20100143466 Modified release ibuprofen dosage form
06/10/2010US20100143465 Pharmaceutical composition
06/10/2010US20100143464 Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same
1 ... 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 ... 7860